Utilize este identificador para referenciar este registo: http://hdl.handle.net/10362/142754
Título: A hypometabolic defense strategy against malaria
Autor: Ramos, Susana
Ademolue, Temitope W
Jentho, Elisa
Wu, Qian
Guerra, Joel
Martins, Rui
Pires, Gil
Weis, Sebastian
Carlos, Ana Rita
Mahú, Inês
Seixas, Elsa
Duarte, Denise
Rajas, Fabienne
Cardoso, Sílvia
Sousa, António G G
Lilue, Jingtao
Paixão, Tiago
Mithieux, Gilles
Nogueira, Fátima
Soares, Miguel P
Palavras-chave: evolutionary trade-off
heme
hypoglycemia
malaria
transmission
virulence
Physiology
Molecular Biology
Cell Biology
Infectious Diseases
Parasitology
SDG 3 - Good Health and Well-being
Data: 2-Ago-2022
Resumo: Hypoglycemia is a clinical hallmark of severe malaria, the often-lethal outcome of Plasmodium falciparum infection. Here, we report that malaria-associated hypoglycemia emerges from a non-canonical resistance mechanism, whereby the infected host reduces glycemia to starve Plasmodium. This hypometabolic response is elicited by labile heme, a byproduct of hemolysis that induces illness-induced anorexia and represses hepatic glucose production. While transient repression of hepatic glucose production prevents unfettered immune-mediated inflammation, organ damage, and anemia, when sustained over time it leads to hypoglycemia, compromising host energy expenditure and adaptive thermoregulation. The latter arrests the development of asexual stages of Plasmodium via a mechanism associated with parasite mitochondrial dysfunction. In response, Plasmodium activates a transcriptional program associated with the reduction of virulence and sexual differentiation toward the generation of transmissible gametocytes. In conclusion, malaria-associated hypoglycemia represents a trade-off of a hypometabolic-based defense strategy that balances parasite virulence versus transmission.
Descrição: Funding Information: We thank Dr. Silvia Portugal (Max Plank Institute, Berlin) and Dr. Jessica Thompson (Instituto Gulbenkian de Ciência; IGC) for their critical review of the manuscript; Dr. Joanne Thompson (University of Edinburgh) for PcAS-GFPML parasites; BEI Resources for P. falciparum parasites (MRA-1029, deposited by Andrew M. Talman and Robert E. Sinden); and excellent support from IGC's Advanced Imaging, Flow Cytometry & Antibody and Genomics facilities. S.R. was supported by Fundação Para a Ciência e Tecnologia (FCT; 5723/2014; FEDER029411); T.W.A. by the Gulbenkian foundation (IBB2017); E.J. by the Deutsche Forschungsgemeinschaft (DFG, EXC 2051; 390713860); A.R.C. by FCT (SFRH/BPD/101608/2014); S.W. and J.G. by the Center for Sepsis Control and Care (CSCC), Jena University Hospital (BMBF 01EO1502), and DFG (EXC 2051, 390713860, and WE 4971/6-1); and D.D. and F.N. by FCT (GHTM; UID/04413/2020). The M.P.S. laboratory is supported by the Gulbenkian, “La Caixa” (HR18-00502), and FCT (5723/2014; FEDER029411) foundations, as well as by the Oeiras-ERC Frontier Research Incentive Awards. M.P.S. is an associate member of the DFG Cluster of Excellence “Balance of the Microverse” (https://microverse-cluster.de/en). Support by Congento (LISBOA-01-0145-FEDER-022170) is acknowledged. Study design, experimental work, data analysis, and interpretation, S.R. and T.W.A.; Plasmodium scRNA data, E.J. (with S.R. and T.W.A.); in vitro experiments on heme regulation of gluconeogenesis, A.R.C. and Q.W.; indirect calorimetry measurements of heme-treated mice, J.G. and S.W.; flow cytometry experiments R.M. (with T.W.A.); Plasmodium virulence experiments, G.P. assisted S.R. and T.W.A.; experiments of induction of illness-induced anorexia in response to Plasmodium infection, I.M. and E.S. assisted S.R. and T.W.A.; maintenance and characterization of mouse strains; S.C.; bulk RNA and scRNA sequencing data analysis, A.G.G.S. and J.L. (with S.R. T.W.A. and E.J.); data interpretation, G.M. and F.R.; P. falciparum glucose tolerance in vitro experiments, F.N. (with S.R. and D.D.); formulation of the original hypothesis, study design, and writing of the manuscript, M.P.S. (with S.R. and T.W.A.). All authors read and approved the manuscript. The authors declare no competing interests. Funding Information: We thank Dr. Silvia Portugal (Max Plank Institute, Berlin) and Dr. Jessica Thompson (Instituto Gulbenkian de Ciência; IGC) for their critical review of the manuscript; Dr. Joanne Thompson (University of Edinburgh) for PcAS-GFP ML parasites; BEI Resources for P. falciparum parasites (MRA-1029, deposited by Andrew M. Talman and Robert E. Sinden); and excellent support from IGC’s Advanced Imaging, Flow Cytometry & Antibody and Genomics facilities. S.R. was supported by Fundação Para a Ciência e Tecnologia (FCT; 5723/2014 ; FEDER029411 ); T.W.A. by the Gulbenkian foundation ( IBB2017 ); E.J. by the Deutsche Forschungsgemeinschaft (DFG, EXC 2051 ; 390713860 ); A.R.C. by FCT ( SFRH/BPD/101608/2014 ); S.W. and J.G. by the Center for Sepsis Control and Care (CSCC), Jena University Hospital ( BMBF 01EO1502 ), and DFG ( EXC 2051 , 390713860 , and WE 4971/6-1 ); and D.D. and F.N. by FCT (GHTM; UID/04413/2020 ). The M.P.S. laboratory is supported by the Gulbenkian, “La Caixa” ( HR18-00502 ), and FCT ( 5723/2014 ; FEDER029411 ) foundations, as well as by the Oeiras-ERC Frontier Research Incentive Awards . M.P.S. is an associate member of the DFG Cluster of Excellence “Balance of the Microverse” ( https://microverse-cluster.de/en ). Support by Congento ( LISBOA-01-0145-FEDER-022170 ) is acknowledged. Publisher Copyright: © 2022 Elsevier Inc.
Peer review: yes
URI: http://hdl.handle.net/10362/142754
DOI: https://doi.org/10.1016/j.cmet.2022.06.011
ISSN: 1550-4131
Aparece nas colecções:Home collection (IHMT)

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
A_hypometabolic_defense_strategy_against_malaria.pdf6,84 MBAdobe PDFVer/Abrir


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.